新辅助直肠癌临床试验中的早期疗效终点：重新审视替代终点。
Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy Revisited.
机构信息
Department of Radiotherapy of Oncology, University of Frankfurt, Frankfurt, Germany.
German Cancer Research Center (DKFZ), Heidelberg, Germany.
出版信息
J Clin Oncol. 2024 Mar 10;42(8):872-875. doi: 10.1200/JCO.23.01196. Epub 2023 Oct 27.
PMID:37890124
Abstract
Trial-level surrogacy is critical before early response endpoints are used to approve new therapies.
摘要
在使用早期反应终点来批准新疗法之前，临床试验中的替代终点是至关重要的。
Zotero 插件